Quantcast

Latest AstraZeneca Stories

2014-06-17 12:28:42

MERIDEN, Conn., June 17, 2014 /PRNewswire/ -- Protein Sciences Corporation announced today that BARDA, within the U.S. Department of Health and Human Services, exercised Option Period 2 of its contract with the Company (contract number HHS0100200900106C) to support development, scale-up and expanded licensure of the Company's influenza vaccines, Flublok® (seasonal) and Panblok® (pandemic). Option Period 2 has a budget of $50.6 million and will run through December 31, 2015. The...

2014-06-17 12:22:45

CARY, N.C., June 17, 2014 /PRNewswire/ -- Summit Agro USA (SAUS) announces the appointment of William (Bill) M. Lewis to the position of President and CEO. Mr. Lewis is replacing Bill Wisdom, who retired at the end of March. Mr. Lewis has extensive agricultural chemical industry experience having held numerous management positions with ICI, Zeneca, Syngenta and Arysta over the past 28 years. In the past two years, Mr. Lewis has owned and operated two John Deere dealerships in the...

2014-06-16 08:29:32

The Lung-MAP trial uses a multi-drug, targeted screening approach to match patients with promising new cancer treatments based on their unique tumor profiles BETHESDA, Md., June 16, 2014 /PRNewswire/ -- A unique public-private collaboration among the National Cancer Institute (NCI), part of the National Institutes of Health, SWOG Cancer Research, Friends of Cancer Research (Friends), the Foundation for the National Institutes of Health (FNIH), five pharmaceutical companies (Amgen,...

2014-06-16 08:28:43

Cell-culture technology is a modern alternative to manufacture influenza vaccines without chicken eggs, with potential to rapidly respond to a pandemic[1] BASEL, Switzerland, June 16, 2014 /PRNewswire/ -- Novartis today announced that the US Food and Drug Administration (FDA) licensed its manufacturing facility in Holly Springs, N.C. for the production of cell-culture influenza vaccines. This is the first US facility of its kind and is now approved for commercial production. The site will...

2014-06-16 00:21:15

- Access to germplasm, seeds pipeline and commercial varieties BASEL, Switzerland, June 16, 2014 /PRNewswire/ -- Syngenta announced today an agreement to acquire the German and Polish winter wheat and winter oilseed rape (WOSR) breeding and business operations of Lantmannen, the Swedish food, energy and agriculture group. Syngenta will gain access to high-quality germplasm, a seeds pipeline and commercial varieties which complement the company's portfolio in two of Europe's...

2014-06-12 23:04:38

ReportsnReports.com adds “PharmaPoint Major Depressive Disorder - Current and Future Players” to its store. Order a purchase copy of this report at http://www.reportsnreports.com/Purchase.aspx?name=288099. Dallas, Texas (PRWEB) June 12, 2014 “PharmaPoint: Major Depressive Disorder - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Major Depressive Disorder Market. The report...

2014-06-12 16:26:24

SAN FRANCISCO, June 12, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) reported today that partner AstraZeneca announced that the majority of US Food and Drug Administration (FDA) Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) members voted that the FDA should not require cardiovascular outcomes trials for the peripherally-acting mu-opioid receptor antagonist (PAMORA) class of drugs, which includes MOVANTIK(TM )(naloxegol oxalate), an investigational...

2014-06-12 08:29:42

DUBLIN, June 12, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/l2jzql/antibacterial) has announced the addition of the "Antibacterial Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 This report on antibacterial drugs market studies the current as well as future prospects of the market globally. The market for antibacterial drugs...

2014-06-11 16:24:35

RnRMarketResearch.com adds "Next-Generation Biologics R&D, Industry and Market 2014-2024" on its store. Order a purchase copy @ http://www.rnrmarketresearch.com/contacts/purchase?rname=185532 . DALLAS, June 11, 2014 /PRNewswire-iReach/ -- Next-generation biologics will address shortcomings in current therapies, including inconvenient dosing and concerns over side effects. Developmental trends include sustained release, for less-frequent dosing, and reformulations for oral and topical...

2014-06-10 08:29:31

Successful collaboration with AstraZeneca includes two novel cancer drugs in clinical development CARLSBAD, Calif., June 10, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that AstraZeneca has initiated a Phase 1 clinical study of ISIS-AR(Rx) in patients with cancer. Isis earned a $15 million milestone payment associated with the clinical advancement of ISIS-AR(Rx). ISIS-AR(Rx) is an antisense drug designed to treat patients with prostate cancer by...


Word of the Day
cock-a-hoop
  • Exultant; jubilant; triumphant; on the high horse.
  • Tipsy; slightly intoxicated.
This word may come from the phrase 'to set cock on hoop,' or 'to drink festively.' Its origin otherwise is unclear. A theory, according to the Word Detective, is that it's a 'transliteration of the French phrase 'coq a huppe,' meaning a rooster displaying its crest ('huppe') in a pose of proud defiance.' Therefore, 'cock-a-hoop' would 'liken a drunken man to a boastful and aggressive rooster.'
Related